Skip to content
Search

Latest Stories

ONLINE EXCLUSIVE: Changes to VAT penalties regime

By Umesh Modi and Vinku Shah

The VAT penalties regime has had substantial changes with effect from 01 January 2023 and it is important for community pharmacy business owners to take note as this is a crucial cash inflow for most. Below we explore the changes that will impact all VAT registered community pharmacy businesses.


Old regime

Prior to 01 January 2023, VAT registered businesses that failed to file their VAT returns or pay any VAT liabilities would be subject to the default surcharge regime. There would be no surcharge for NIL or repayment VAT returns which would apply to most community pharmacy businesses.

New regime

For VAT periods starting on or after 01 January 2023, the default surcharge will be replaced by a new VAT penalties and interest regime if you submit your VAT returns late or pay your VAT liability late.

If you pay your VAT monthly or quarterly, the deadline for filing your VAT return and paying any VAT liabilities is one calendar month and 7 days after the end of the respective period. For example, if you are filing the VAT return for the month or quarter ended 30 June 2022, the deadline for filing will be 07 August 2022. The liability must also be paid and cleared by that date.

The new penalties and interest regime will now also include nil or repayment returns and all returns will be subject to late submission penalty points and financial penalties.

Late filing of VAT returns

Late submission penalties will be based on a points system. For each late VAT return (including Nil or repayment VAT returns), one penalty point will be received. Once a penalty point threshold is reached, a £200 penalty will be levied and a further £200 for each subsequent late submission. The late submission penalty points threshold will depend on your VAT return submission frequency i.e., whether monthly, quarterly, or annual VAT returns.

The points will reset to zero if you submit your VAT returns on or before the due date for your period of compliance and ensure all outstanding returns due for the previous 24 months have been received by HMRC. The table below summarizes the penalty points and compliance period.

Submission frequencyPenalty points thresholdPeriod of compliance
Annually224 months
Quarterly412 months
Monthly56 months

HMRC repayment timelines

HMRC has strict time limits to conform to when making VAT repayments. Repayments should be made within 30 days of the date on which the VAT return has been filed. The 30-day timeline starts from the day HMRC receives your VAT return and ends the day your repayment is approved and not when you receive your VAT refund.

Please be aware that HMRC does not count the time taken to check the accuracy of your VAT return, and to correct any errors and omissions as part of this 30-day period therefore it is crucial that you get your VAT returns right and submitted in time otherwise you could be waiting for your VAT refund longer than expected.

HMRC repayments

HMRC repayments are generally made within the time limits discussed above but if your VAT returns are overdue, HMRC will only release the VAT repayments once all outstanding VAT returns have been brought up to date. When a number of outstanding VAT returns are filed together, there is always a possibility that HMRC may enquire into those VAT return therefore the business could have a substantial cash inflow delay.

Repayment supplement

If you accounting period started on or before 31 December 2022 and HMRC does not repay the VAT in time, the business may be entitled to a repayment supplement. To qualify for a repayment supplement, the VAT return must have been filed on time and accurate to within £250 or, if higher, 5% of the repayment claim.

If HMRC does not pay the repayment on time and the above conditions are met, the business would be entitled to a repayment supplement of 5% of the repayment, with a minimum of £50. Repayment supplement will not be available for outstanding VAT returns.

Repayment interest

The repayment supplement will be withdrawn from 1 January 2023.

For accounting periods starting on or after 1 January 2023, HMRC will pay you repayment interest on any VAT that you are owed, provided the VAT returns have been filed on time.

This will be calculated from the day after the due date or the date of submission (whichever is later) and until the day HMRC pays you the repayment VAT amount due to you in full. Repayment interest will be calculated as the Bank of England base rate minus 1%. The minimum rate of repayment interest will always be 0.5% even if the repayment interest calculation results in a lower percentage.

Late payment of VAT

If your VAT return is not a nil or repayment return, the sooner you pay your VAT liability, the lower the penalty rate will be.

Up to 15 days overdue

You will not be charged a penalty if you pay the VAT you owe in full or agree a payment plan on or between days 1 and 15.

Between 16 and 30 days overdue

You will receive a first penalty calculated at 2% on the VAT you owe at day 15 if you pay in full or agree a payment plan on or between days 16 and 30.

31 days or more overdue

You will receive a first penalty calculated at 2% on the VAT you owe at day 15 plus 2% on the VAT you owe at day 30. You will receive a second penalty calculated at a daily rate of 4% per year for the duration of the outstanding balance. This is calculated when the outstanding balance is paid in full, or a payment plan is agreed.

Period of familiarisation

To give you time to get used to the changes, HMRC will not be charging a first late payment penalty for the first year from 1 January 2023 until 31 December 2023, if you pay in full within 30 days of your payment due date.

Late payment interest

From 1 January 2023, HMRC will charge late payment interest from the day your payment is overdue to the day your payment is made in full. Late payment interest is calculated as the Bank of England base rate plus 2.5%.

Whether you have a nil return, repayment return, or a VAT liability on your VAT returns, you must file your VAT returns as well as pay any liability on time to avoid unnecessary penalties for late filing of VAT returns or late payment of VAT liabilities. Late filing of a repayment VAT return could have a greater adverse effect on the business than penalties in terms of cash flow.

This article is based on current practice and is for guidance only. Specific professional advice should be taken before acting on matters mentioned here. Umesh Modi BA ACA is a Chartered Accountant and Tax Advisor, and a partner at Silver Levene LLP. He can be contacted on 020 7383 3200 or umesh.modi@silverlevene.co.uk. Vinku Shah FCCA is a Chartered Certified Accountant and Manager at Silver Levene LLP. He can be contacted on 020 7383 3200 or vinku.shah@ silverlevene.co.uk.

More For You

How Peptides Are Transforming Modern Drug Development

Modern Drug Development

How Peptides Are Transforming Modern Drug Development

The pharmaceutical industry is rapidly evolving, embracing new technologies and methodologies. Peptides are emerging as a crucial component in this transformation, offering innovative solutions to drug development. This shift is not only reshaping how drugs are discovered but also enhancing their efficacy and safety.

In recent years, the pharmaceutical landscape has undergone significant changes, driven by advancements in technology and scientific understanding. One of the most promising areas of innovation is the use of peptides in drug development. These short chains of amino acids have proven to be versatile tools, capable of targeting specific cells or molecules with high precision. In this context, certain bpc 157 peptide research peptides have been highlighted for their potential applications in various therapeutic areas, showcasing the promise that peptides hold for modern pharmaceutical studies.

Keep ReadingShow less
Janet Morrison discusses pharmacy funding strategy at 2025 conference

Health Secretary Wes Streeting outlines government support for community pharmacy

CPE calls new funding deal a ‘reluctant yes’

Community Pharmacy England (CPE) was “reluctant” to accept the new pharmacy funding deal due to the significant funding gap, said the organisation’s chief executive Janet Morrison, while recognising the settlement as the first step towards stabilising the sector.

Addressing the 2025 Pharmacy Business Conference on Sunday at London Hilton Wembley, Janet shared insights into the behind-the-scenes work that led to the agreement.

Keep ReadingShow less
RPS transition to Royal College

RPS transition to Royal College: What it means for pharmacy

RPS transition to Royal College: What it means for pharmacy - Professor Claire Anderson explains

The Royal Pharmaceutical Society (RPS) is set to transition into a Royal College after securing majority support from its members in a recent ballot. However, concerns have been raised about the long-term implications of this shift.

With a voter turnout of 31.4%, 6,144 out of 19,594 eligible members participated in the vote on the Royal Charter changes. Of those, 71.1% supported the transition, well above the required two-thirds majority for a Special Resolution Vote.

Keep ReadingShow less
Pharmacies key to driving the shift from treatment to prevention

Bas Vorsteveld, Kenvue’s area managing director for Northern Europe.

Pharmacies can become frontline educators of self-care

Pharmacies have the potential to play a pivotal role in the government's transition from treatment-based healthcare to a more prevention-focused approach. However, for this shift to be successful, they require greater systemic support.

Bas Vorsteveld, Kenvue’s area managing director for Northern Europe, emphasises the importance of allowing pharmacists access to patient records to enable them to offer tailored advice and improve patient care.

Keep ReadingShow less
Community pharmacist consulting with a patient about independent prescribing.

Malcolm Harrison

Exclusive: National prescribing service 'critical' for community pharmacy, says Malcolm Harrison

A national prescribing service is “critical” for community pharmacy with all newly qualified pharmacists becoming independent prescribers from next year, according to Malcolm Harrison, chief executive of the Company Chemist Association (CCA).

“We are encouraging the NHS to work with community pharmacy to explore what that (prescribing service) could look like. There are pilots that are out there at the moment, and I know a number of pharmacies are engaged in those and exploring the different variations of what it could be,” Harrison told Pharmacy Business.

Keep ReadingShow less